Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • October 18, 2018 9:22 AM | Anonymous

    October 18, 2018, The Pharma Letter 

    The U.S. Food and Drug Administration approved Talzenna (talazoparib), a poly (ADP-ribose) polymerase (PARP) inhibitor, for patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), HER2‑negative locally advanced or metastatic breast cancer. Patients must be selected for therapy based on an FDA-approved companion diagnostic for talazoparib. 

    Read more.

  • October 18, 2018 9:20 AM | Anonymous

    October 18, 2018, HealthDay News via Medical Xpress

    American women are having fewer children, and they're having them later in life, a new government report shows. "Overall, we saw continuing decreasing trends in total fertility," said report author Danielle Ely, a health statistician at the National Center for Health Statistics (NCHS), which is part of the U.S. Centers for Disease Control and Prevention.  

    Read more.

  • October 18, 2018 9:00 AM | Anonymous

    October 18, 2018, via ACOG

    Attend the Education in Women's Genomics Counseling course on Friday, December 7, 2018 in Washington, D.C.
    This grant-based course is designed to enhance physicians' knowledge and application of genomic technologies in the fields of reproductive healthcare. 


    Learn how to solicit a family history to identify appropriate genetic screening, how to counsel a preconception and prenatal patient on new carrier screening and aneuploidy screening options, and the implications of positive and negative test results. You will be able to discuss the pros and cons of new genetic test options for patients seeking prenatal diagnostic testing and recognize and counsel patients about hereditary cancer syndromes relevant to women's health and develop an evidence-based testing strategy.


    1. Attend the didactic lecture ($99 holding fee refunded upon attendance)
    2. Complete eight online modules by April 30, 2019 (information to be provided) 
    3. Attend a three-hour lecture in person at the 2019 ACOG Annual Clinical and Scientific Meeting on May 5 or virtually up to seven days after the course
    4. Successfully complete posttest 

    Questions? Contact the genomics team at
  • October 17, 2018 1:47 PM | Anonymous

    October 17, 2018   

    Save the date for AAPA 2019 in Denver Colorado, May 18-22, 2019! 

    Plans for APAOG members include an awards reception and dinner. Meet fellow APAOG members as you come together  to learn about all things PA at AAPA 2019! 

    More information to come. Stay tuned! 

  • October 17, 2018 1:45 PM | Anonymous

    MedPage Today, October 17, 2018  

    Most examined patients with HIV who survived more than 2 years after allogeneic hematopoietic stem cell transplant (allo-HSCT) had undetectable HIV DNA and undetectable replication-competent virus, a small observational study found. 

    Read more.

  • October 17, 2018 1:43 PM | Anonymous

    Medgadget, October 17, 2018  

    GE Healthcare is unveiling its brand new Invenia Automated Breast Ultrasound (ABUS) 2.0 in the U.S. It is the only U.S. Food and Drug Administration approved "ultrasound supplemental breast screening technology," which allows for spotting of cancerous lesions within dense breast tissue, according to GE. 

    Read more.

  • October 12, 2018 9:04 AM | Anonymous

    October 12, 2018, The Daily Telegraph  

    Women could be spared the heartbreak of miscarriage thanks to artificial intelligence that can help to spot which pregnancies will fail. The breakthrough works with IVF treatment, using a super-computer to pick out "good" embryos — or "bad" ones, which could prevent a woman from giving birth or cause her to miscarry.

    Read more.

  • October 10, 2018 7:38 AM | Anonymous

    October 10, 2018, News Medical 

    The proportion of breast cancer patients who are eligible for breast conservation therapy, yet opt for mastectomy, is increasing, for reasons that include the desire to eliminate future screening and/or biopsy of the remaining breast tissue. A new study led by researchers at the Icahn School of Medicine at Mount Sinai has determined that having a mastectomy does not completely eliminate the need for further breast imaging studies.  

    Read more.

  • October 09, 2018 6:59 AM | Anonymous

    October 9, 2018, HealthDay News  

    More than 14 million additional 11- to 12-year-olds need to be vaccinated to reach the American Cancer Society goal of 80 percent of adolescents being up to date (UTD) with the human papillomavirus vaccination (HPVV) by their 13th birthday by 2026, according to a study published online in Cancer. 

    Read more.

  • October 06, 2018 8:19 AM | Anonymous


    PA Week is here, and we have everything you need to celebrate. Print banners, promote the profession, participate in our Instagram photo contest, watch our PA Week Video contest submissions and vote for your favorite, and — most importantly, share your PA pride! 

    Read more.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
Powered by Wild Apricot Membership Software